Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

by Alonso Daniel F, Gomez Daniel E, Otero Laura L, Gabri Mariano R
Published 2009-12-01

Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

by Alonso Daniel F, Gómez Roberto, Ramos Thelvia, Castillo Dagnelia, Díaz Alina, González Carlos A, Valenzuela Carmen, Baladrón Idania, Santana Agueda, Solares Ana M, Herrera Luis, Sigman Hugo, Perea Silvio E, Acevedo Boris E, López-Saura Pedro
Published 2009-05-01